Search results
Results from the WOW.Com Content Network
Recurrent or refractory bleeding may lead to need for surgery, although this has become uncommon as a result of improved endoscopic and medical treatment. Upper gastrointestinal bleeding affects around 50 to 150 people per 100,000 a year. It represents over 50% of cases of gastrointestinal bleeding. [2]
Mallory–Weiss syndrome is a condition where high intra-abdominal pressures causes laceration and bleeding of the mucosa called Mallory-Weiss tears. [1] Additionally, Mallory–Weiss syndrome is one of the most common causes of acute upper gastrointestinal bleeding, counting of around 1-15% of all cases in adults and less than 5% in children.
An upper GI bleed is more common than lower GI bleed. [2] An upper GI bleed occurs in 50 to 150 per 100,000 adults per year. [8] A lower GI bleed is estimated to occur in 20 to 30 per 100,000 per year. [2] It results in about 300,000 hospital admissions a year in the United States. [1] Risk of death from a GI bleed is between 5% and 30%.
About 900 people die of norovirus every year (mostly patients over the age of 65), and 109,000 people are hospitalized with it, reports the American Medical Association.
Dieulafoy's lesions account for roughly 1.5 percent of gastrointestinal hemorrhage. [11] These lesions are twice as common in men, and often occur in older individuals (over 50 years of age) with multiple comorbidities, including hypertension, cardiovascular disease, chronic kidney disease, and diabetes.
The average age of diagnosis for GAVE is 73 years of age for females, [3] [7] and 68 for males. [2] Women are about twice as often diagnosed with gastric antral vascular ectasia than men. [2] [7] 71% of all cases of GAVE are diagnosed in females. [3] [7] Patients in their thirties have been found to have GAVE. [6]
However, the lesions may be widespread, making such treatment impractical. [citation needed] If the bleeding is from multiple or inaccessible sites, systemic therapy with medication may be necessary. First-line options include the antifibrinolytics tranexamic acid or aminocaproic acid. Estrogens can be used to stop bleeding from angiodysplasia.
Now, the Centers for Disease Control and Prevention (CDC) has released new guidance for the COVID-19 vaccine for those over 65 years old and/or immunocompromised.